Macauley Matthew S, Paulson James C
Department of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037; and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.
Department of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037; and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037
J Immunol. 2014 Nov 1;193(9):4312-21. doi: 10.4049/jimmunol.1401723. Epub 2014 Sep 24.
Infusion of blood cells from a donor can induce humoral tolerance in a recipient and increase the probability of successful organ transplant, a clinical method defined as donor-specific transfusion (DST). Despite the clinical success of DST, the immunological mechanisms by which blood cells displaying a foreign Ag induce tolerance remain poorly understood. Based on recent findings showing that the B cell siglecs, CD22 and Siglec-G, can promote tolerance to Ags presented on the same surface as their ligands, we speculated that the B cell siglecs are key players in tolerance induced by DST. Using a variety of chemical and genetic approaches, we show that the B cell siglecs mediate tolerance to cell surface Ags by initiating an inhibitory signal that culminates in elimination of the Ag-reactive B cell. CD22 and Siglec-G are recruited to the immunological synapse by sialic acid ligands on the Ag-bearing cells, producing a tolerogenic signal involving Lyn and the proapoptotic factor BIM that promotes deletion of the B cell and failure of mice to develop Abs to the Ag upon subsequent challenge. We speculate that this tolerogenic mechanism is a contributing factor in DST and a mechanism of peripheral B cell tolerance to cell surface autoantigens.
输注来自供体的血细胞可诱导受体产生体液耐受,并增加器官移植成功的概率,这种临床方法被定义为供体特异性输血(DST)。尽管DST在临床上取得了成功,但血细胞呈现外来抗原诱导耐受的免疫机制仍知之甚少。基于最近的研究结果表明B细胞唾液酸结合凝集素CD22和Siglec-G能够促进对与其配体在同一表面呈现的抗原的耐受,我们推测B细胞唾液酸结合凝集素是DST诱导耐受的关键因素。通过使用各种化学和遗传学方法,我们发现B细胞唾液酸结合凝集素通过启动一个抑制性信号来介导对细胞表面抗原的耐受,该信号最终导致消除抗原反应性B细胞。CD22和Siglec-G被含抗原细胞上的唾液酸配体招募到免疫突触,产生一个涉及Lyn和促凋亡因子BIM的致耐受信号,促进B细胞的缺失以及小鼠在随后受到攻击时无法产生针对该抗原的抗体。我们推测这种致耐受机制是DST的一个促成因素,也是外周B细胞对细胞表面自身抗原耐受的一种机制。